Ignite Creation Date:
2024-05-06 @ 10:10 AM
Last Modification Date:
2024-10-26 @ 12:26 PM
Study NCT ID:
NCT03182257
Status:
TERMINATED
Last Update Posted:
2019-09-13
First Post:
2017-05-19
Brief Title:
Study of ONO-7579 in Patients With Advanced Solid Tumors NTRK Gene Fusion Positive Advanced Solid Tumors
Sponsor:
Ono Pharmaceutical Co Ltd
Organization:
Ono Pharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
Keywords:
| Name | View |
|---|---|
| TRK | View |
| TRKA | View |
| TRKB | View |
| TRKC | View |
| NTRK1 | View |
| NTRK2 | View |
| NTRK3 | View |
| NTRK fusion positive | View |
| NTRK1 fusion | View |
| NTRK2 fusion | View |
| NTRK3 fusion | View |
| NTRK1 gene rearrangement | View |
| NTRK2 gene rearrangement | View |
| NTRK3 gene fusion | View |
| ETV6-NTRK3 | View |
| fusion | View |
| tumors | View |
| solid tumors | View |
| CNS tumors | View |
| central nervous system tumors | View |
| TRK fusion | View |
| ETV6 | View |
| ETV6 fusion | View |
| solid CNS tumor | View |
| advanced CNS tumor | View |
| primary CNS tumor | View |